Xu S - Search Results

1

Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function.

Deng M, Su D, Xu S, Little PJ, Feng X, Tang L, Shen A. Deng M, et al. Among authors: xu s. Front Pharmacol. 2020 May 8;11:635. doi: 10.3389/fphar.2020.00635. eCollection 2020. Front Pharmacol. 2020. PMID: 32457625 Free PMC article. Review.

2

Cardiovascular actions and therapeutic potential of tanshinone IIA.

Gao S, Liu Z, Li H, Little PJ, Liu P, Xu S. Gao S, et al. Among authors: xu s. Atherosclerosis. 2012 Jan;220(1):3-10. doi: 10.1016/j.atherosclerosis.2011.06.041. Epub 2011 Jun 30. Atherosclerosis. 2012. PMID: 21774934 Review.

3

Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet.

Xu S, Little PJ, Lan T, Huang Y, Le K, Wu X, Shen X, Huang H, Cai Y, Tang F, Wang H, Liu P. Xu S, et al. Arch Biochem Biophys. 2011 Nov;515(1-2):72-9. doi: 10.1016/j.abb.2011.08.006. Epub 2011 Aug 26. Arch Biochem Biophys. 2011. PMID: 21889487

4

Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.

Xu S, Liu Z, Huang Y, Le K, Tang F, Huang H, Ogura S, Little PJ, Shen X, Liu P. Xu S, et al. Transl Res. 2012 Aug;160(2):114-24. doi: 10.1016/j.trsl.2012.01.008. Epub 2012 Feb 2. Transl Res. 2012. PMID: 22677363

5

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.

Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P. Xu S, et al. Cell Mol Life Sci. 2013 Aug;70(16):2859-72. doi: 10.1007/s00018-012-1194-z. Epub 2012 Nov 3. Cell Mol Life Sci. 2013. PMID: 23124189 Free PMC article. Review.

6

Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.

Kamato D, Burch ML, Piva TJ, Rezaei HB, Rostam MA, Xu S, Zheng W, Little PJ, Osman N. Kamato D, et al. Among authors: xu s. Cell Signal. 2013 Oct;25(10):2017-24. doi: 10.1016/j.cellsig.2013.06.001. Epub 2013 Jun 11. Cell Signal. 2013. PMID: 23770288 Review.

7

Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.

Xu S, Bai P, Little PJ, Liu P. Xu S, et al. Med Res Rev. 2014 May;34(3):644-75. doi: 10.1002/med.21300. Epub 2013 Sep 3. Med Res Rev. 2014. PMID: 24002940 Review.

8

Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1.

Liu Z, Wang J, Huang E, Gao S, Li H, Lu J, Tian K, Little PJ, Shen X, Xu S, Liu P. Liu Z, et al. Among authors: xu s. J Lipid Res. 2014 Feb;55(2):201-13. doi: 10.1194/jlr.M040394. Epub 2013 Dec 3. J Lipid Res. 2014. PMID: 24302760 Free PMC article.

9

Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling.

Wang J, Liu Z, Feng X, Gao S, Xu S, Liu P. Wang J, et al. Among authors: xu s. Arch Biochem Biophys. 2014 Nov 15;562:22-30. doi: 10.1016/j.abb.2014.08.007. Epub 2014 Aug 20. Arch Biochem Biophys. 2014. PMID: 25151306

10

SIRT6 protects against endothelial dysfunction and atherosclerosis in mice.

Xu S, Yin M, Koroleva M, Mastrangelo MA, Zhang W, Bai P, Little PJ, Jin ZG. Xu S, et al. Aging (Albany NY). 2016 May;8(5):1064-82. doi: 10.18632/aging.100975. Aging (Albany NY). 2016. PMID: 27249230 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,186 results

Search Page

Filters